Last update 06 Nov 2024

PVX-410

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
PVX 410
Mechanism
CD138 inhibitors(Syndecan-1 inhibitors), SLAMF7 inhibitors(SLAM family member 7 inhibitors), XBP1 inhibitors(X-box binding protein 1 inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Triple-Negative Breast CarcinomaPhase 2-30 Apr 2022
PD-L1 negative Triple Negative Breast CancerPhase 2-30 Apr 2022
Multiple MyelomaPhase 2
US
-15 Apr 2016
Triple Negative Breast CancerPhase 1
US
01 Aug 2016
Smoldering Multiple MyelomaPhase 1
US
01 Nov 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
22
zjryvubbjt(hiegwbbizi) = odlxxpihif qttopthrqg (ctnyampffg )
Positive
01 Dec 2018
Lenalidomide+PVX-410 Vaccine
atgxtdtosj(zhlydcwkob) = qieshxdmen tkbzkqcyac (ujswpuysfd )
Phase 1/2
26
Durvalumab+PVX 410
zwujaomlir(cozdburfup) = wzdznynmaj jobaenqfne (pdptjuhjhy )
Positive
28 Nov 2016
zwujaomlir(cozdburfup) = qzfkjumlvi jobaenqfne (pdptjuhjhy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free